These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37319310)

  • 1. T-BACCO SCORE: A predictive scoring tool for tuberculosis (TB) loss to follow-up among TB smokers.
    Sharani ZZ; Ismail N; Yasin SM; Isa MR; Razali A; Sherzkawee MA; Ismail AI
    PLoS One; 2023; 18(6):e0287374. PubMed ID: 37319310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and determinants of loss to follow-up among tuberculosis (TB) patients who smoke in an industrial state of Malaysia: a registry-based study of the years 2013-2017.
    Sharani ZZ; Ismail N; Yasin SM; Zakaria Y; Razali A; Demong NAR; Mohammad M; Ismail Z
    BMC Public Health; 2022 Apr; 22(1):638. PubMed ID: 35365112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
    Nguyen DT; Jenkins HE; Graviss EA
    PLoS One; 2018; 13(4):e0196022. PubMed ID: 29659636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prognostic score to predict tuberculosis mortality.
    Nguyen DT; Graviss EA
    J Infect; 2018 Oct; 77(4):283-290. PubMed ID: 29649520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
    PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment.
    Rodrigues MMS; Barreto-Duarte B; Vinhaes CL; Araújo-Pereira M; Fukutani ER; Bergamaschi KB; Kristki A; Cordeiro-Santos M; Rolla VC; Sterling TR; Queiroz ATL; Andrade BB
    BMC Public Health; 2024 May; 24(1):1385. PubMed ID: 38783264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    Baik Y; Rickman HM; Hanrahan CF; Mmolawa L; Kitonsa PJ; Sewelana T; Nalutaaya A; Kendall EA; Lebina L; Martinson N; Katamba A; Dowdy DW
    PLoS Med; 2020 Nov; 17(11):e1003420. PubMed ID: 33170838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
    Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
    BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning algorithms using national registry data to predict loss to follow- up during tuberculosis treatment.
    Rodrigues MMS; Barreto-Duarte B; Vinhaes CL; Araújo-Pereira M; Fukutani ER; Bergamaschi KB; Kristki A; Cordeiro-Santos M; Rolla VC; Sterling TR; Queiroz ATL; Andrade BB
    Res Sq; 2023 Dec; ():. PubMed ID: 38168296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
    Mando TC; Sandy C; Chadambuka A; Gombe NT; Juru TP; Shambira G; Umeokonkwo CD; Tshimanga M
    PLoS One; 2023; 18(11):e0293867. PubMed ID: 37939099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.
    Madan C; Chopra KK; Satyanarayana S; Surie D; Chadha V; Sachdeva KS; Khanna A; Deshmukh R; Dutta L; Namdeo A; Shukla A; Sagili K; Chauhan LS
    PLoS One; 2018; 13(10):e0204982. PubMed ID: 30281679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prognostic score during tuberculosis treatment.
    Pefura-Yone EW; Balkissou AD; Poka-Mayap V; Fatime-Abaicho HK; Enono-Edende PT; Kengne AP
    BMC Infect Dis; 2017 Apr; 17(1):251. PubMed ID: 28388895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the risk of active pulmonary tuberculosis in people living with HIV: development and validation of a nomogram.
    Chen J; Li L; Chen T; Yang X; Ru H; Li X; Yang X; Xie Q; Xu L
    BMC Infect Dis; 2022 Apr; 22(1):388. PubMed ID: 35439965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a risk score to predict mortality during TB treatment in patients with TB-diabetes comorbidity.
    Nguyen DT; Graviss EA
    BMC Infect Dis; 2019 Jan; 19(1):10. PubMed ID: 30611208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
    Mann TN; Davis JH; Dyers R
    S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.